Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation

Departments of 1 Medicine, 2 Pharmacology and Therapeutics, and 3 Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada; and 4 Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico Submitted 15 September 2007 ; accepted in final form 6 February 2008 In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2008-04, Vol.294 (4), p.H1724-H1735
Hauptverfasser: Mink, Steven N, Kasian, Krika, Santos Martinez, Luis E, Jacobs, Hans, Bose, Ratna, Cheng, Zhao-Qin, Light, R. Bruce
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H1735
container_issue 4
container_start_page H1724
container_title American journal of physiology. Heart and circulatory physiology
container_volume 294
creator Mink, Steven N
Kasian, Krika
Santos Martinez, Luis E
Jacobs, Hans
Bose, Ratna
Cheng, Zhao-Qin
Light, R. Bruce
description Departments of 1 Medicine, 2 Pharmacology and Therapeutics, and 3 Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada; and 4 Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico Submitted 15 September 2007 ; accepted in final form 6 February 2008 In septic shock, systemic vasodilation and myocardial depression contribute to the systemic hypotension observed. Both components can be attributed to the effects of mediators that are released as part of the inflammatory response. We previously found that lysozyme (Lzm-S), released from leukocytes, contributed to the myocardial depression that develops in a canine model of septic shock. Lzm-S binds to the endocardial endothelium, resulting in the production of nitric oxide (NO), which, in turn, activates the myocardial soluble guanylate cyclase (sGC) pathway. In the present study, we determined whether Lzm-S might also play a role in the systemic vasodilation that occurs in septic shock. In a phenylephrine-contracted canine carotid artery ring preparation, we found that both canine and human Lzm-S, at concentrations similar to those found in sepsis, produced vasorelaxation. This decrease in force could not be prevented by inhibitors of NO synthase, prostaglandin synthesis, or potassium channel inhibitors and was not dependent on the presence of the vascular endothelium. However, inhibitors of the sGC pathway prevented the vasodilatory activity of Lzm-S. In addition, Aspergillus niger catalase, which breaks down H 2 O 2 , as well as hydroxyl radical scavengers, which included hydroquinone and mannitol, prevented the effect of Lzm-S. Electrochemical sensors corroborated that Lzm-S caused H 2 O 2 release from the carotid artery preparation. In conclusion, these results support the notion that when Lzm-S interacts with the arterial vasculature, this interaction results in the formation of H 2 O 2 , which, in turn, activates the sGC pathway to cause relaxation. Lzm-S may contribute to the vasodilation that occurs in septic shock. reactive oxygen species; catalase; compound I; hydroxyl radical; septic shock; hypotension Address for reprint requests and other correspondence: S. N. Mink, Health Sciences Centre, GF-221, 820 Sherbrook St., Winnipeg, Manitoba, Canada R3A 1R9 (e-mail: minksn{at}cc.umanitoba.ca )
doi_str_mv 10.1152/ajpheart.01072.2007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_229675813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1460409241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-752ea63a2b08bd4c68cf0ca41c7322bab4c8b558514047cc1d90eb0c46e971033</originalsourceid><addsrcrecordid>eNp1kF2L1DAYhYMo7rj6CwQJXtvZfDYtXsniusKAN-t1SNO3bYZOU5PU3frrzeyMqzdC4L3IeQ6HB6G3lGwplezK7OcBTEhbQoliW0aIeoY2-YcVVPL6OdoQXvKipFxeoFcx7gkhUpX8JbqgFSu5omKD4m6N_td6gA_Y4AO0ziQfsO9whDm6iNNgEp6DbxcLEf800bduNMn5CTcrHtY2-B4mPEPwD64FHF0_mdFNPXYTNvmFBMGZMXfAbMIj-Rq96MwY4c35XqLvN5_vrm-L3bcvX68_7QorGEuFkgxMyQ1rSNW0wpaV7Yg1glrFGWtMI2zVSFlJKohQ1tK2JtAQK0qoFSWcX6L3p968_8cCMem9X0KeFzVjdalkRY8hfgrZ4GMM0Ok5uIMJq6ZEHz3rP571o2d99Jypd-fqpcnW_jJnsTnw8RQYXD_cuwB6Htbo_Oj7Vd8s43gHD-mpmtVCC31LFRN6brtMX_2fftrzD8V_Axkko48</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229675813</pqid></control><display><type>article</type><title>Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mink, Steven N ; Kasian, Krika ; Santos Martinez, Luis E ; Jacobs, Hans ; Bose, Ratna ; Cheng, Zhao-Qin ; Light, R. Bruce</creator><creatorcontrib>Mink, Steven N ; Kasian, Krika ; Santos Martinez, Luis E ; Jacobs, Hans ; Bose, Ratna ; Cheng, Zhao-Qin ; Light, R. Bruce</creatorcontrib><description>Departments of 1 Medicine, 2 Pharmacology and Therapeutics, and 3 Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada; and 4 Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico Submitted 15 September 2007 ; accepted in final form 6 February 2008 In septic shock, systemic vasodilation and myocardial depression contribute to the systemic hypotension observed. Both components can be attributed to the effects of mediators that are released as part of the inflammatory response. We previously found that lysozyme (Lzm-S), released from leukocytes, contributed to the myocardial depression that develops in a canine model of septic shock. Lzm-S binds to the endocardial endothelium, resulting in the production of nitric oxide (NO), which, in turn, activates the myocardial soluble guanylate cyclase (sGC) pathway. In the present study, we determined whether Lzm-S might also play a role in the systemic vasodilation that occurs in septic shock. In a phenylephrine-contracted canine carotid artery ring preparation, we found that both canine and human Lzm-S, at concentrations similar to those found in sepsis, produced vasorelaxation. This decrease in force could not be prevented by inhibitors of NO synthase, prostaglandin synthesis, or potassium channel inhibitors and was not dependent on the presence of the vascular endothelium. However, inhibitors of the sGC pathway prevented the vasodilatory activity of Lzm-S. In addition, Aspergillus niger catalase, which breaks down H 2 O 2 , as well as hydroxyl radical scavengers, which included hydroquinone and mannitol, prevented the effect of Lzm-S. Electrochemical sensors corroborated that Lzm-S caused H 2 O 2 release from the carotid artery preparation. In conclusion, these results support the notion that when Lzm-S interacts with the arterial vasculature, this interaction results in the formation of H 2 O 2 , which, in turn, activates the sGC pathway to cause relaxation. Lzm-S may contribute to the vasodilation that occurs in septic shock. reactive oxygen species; catalase; compound I; hydroxyl radical; septic shock; hypotension Address for reprint requests and other correspondence: S. N. Mink, Health Sciences Centre, GF-221, 820 Sherbrook St., Winnipeg, Manitoba, Canada R3A 1R9 (e-mail: minksn{at}cc.umanitoba.ca )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.01072.2007</identifier><identifier>PMID: 18263714</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject><![CDATA[Aminoquinolines - pharmacology ; Animals ; Blood vessels ; Carotid Artery, Internal - drug effects ; Carotid Artery, Internal - enzymology ; Carotid Artery, Internal - metabolism ; Catalase - metabolism ; Cells ; Cyclic GMP - analogs & derivatives ; Cyclic GMP - metabolism ; Cyclic GMP - pharmacology ; Cyclic GMP-Dependent Protein Kinases - antagonists & inhibitors ; Cyclic GMP-Dependent Protein Kinases - metabolism ; Cyclooxygenase Inhibitors - pharmacology ; Dogs ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; Enzymes ; Ethanol - pharmacology ; Free Radical Scavengers - pharmacology ; Guanylate Cyclase - antagonists & inhibitors ; Guanylate Cyclase - metabolism ; Humans ; Hydrogen Peroxide - metabolism ; Hydroquinones - pharmacology ; In Vitro Techniques ; Indomethacin - pharmacology ; Mannitol - pharmacology ; Mesenteric Artery, Superior - drug effects ; Mesenteric Artery, Superior - enzymology ; Mesenteric Artery, Superior - metabolism ; Methylene Blue - pharmacology ; Muramidase - antagonists & inhibitors ; Muramidase - metabolism ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Synthase - antagonists & inhibitors ; Nitric Oxide Synthase - metabolism ; omega-N-Methylarginine - pharmacology ; Oxadiazoles - pharmacology ; Phenylephrine - pharmacology ; Prostaglandins - metabolism ; Protein Kinase Inhibitors - pharmacology ; Quinoxalines - pharmacology ; Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors ; Receptors, Cytoplasmic and Nuclear - metabolism ; Sepsis - metabolism ; Sepsis - physiopathology ; Signal transduction ; Signal Transduction - drug effects ; Soluble Guanylyl Cyclase ; Studies ; Thionucleotides - pharmacology ; Time Factors ; Vasoconstrictor Agents - pharmacology ; Vasodilation - drug effects]]></subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2008-04, Vol.294 (4), p.H1724-H1735</ispartof><rights>Copyright American Physiological Society Apr 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-752ea63a2b08bd4c68cf0ca41c7322bab4c8b558514047cc1d90eb0c46e971033</citedby><cites>FETCH-LOGICAL-c422t-752ea63a2b08bd4c68cf0ca41c7322bab4c8b558514047cc1d90eb0c46e971033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18263714$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mink, Steven N</creatorcontrib><creatorcontrib>Kasian, Krika</creatorcontrib><creatorcontrib>Santos Martinez, Luis E</creatorcontrib><creatorcontrib>Jacobs, Hans</creatorcontrib><creatorcontrib>Bose, Ratna</creatorcontrib><creatorcontrib>Cheng, Zhao-Qin</creatorcontrib><creatorcontrib>Light, R. Bruce</creatorcontrib><title>Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>Departments of 1 Medicine, 2 Pharmacology and Therapeutics, and 3 Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada; and 4 Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico Submitted 15 September 2007 ; accepted in final form 6 February 2008 In septic shock, systemic vasodilation and myocardial depression contribute to the systemic hypotension observed. Both components can be attributed to the effects of mediators that are released as part of the inflammatory response. We previously found that lysozyme (Lzm-S), released from leukocytes, contributed to the myocardial depression that develops in a canine model of septic shock. Lzm-S binds to the endocardial endothelium, resulting in the production of nitric oxide (NO), which, in turn, activates the myocardial soluble guanylate cyclase (sGC) pathway. In the present study, we determined whether Lzm-S might also play a role in the systemic vasodilation that occurs in septic shock. In a phenylephrine-contracted canine carotid artery ring preparation, we found that both canine and human Lzm-S, at concentrations similar to those found in sepsis, produced vasorelaxation. This decrease in force could not be prevented by inhibitors of NO synthase, prostaglandin synthesis, or potassium channel inhibitors and was not dependent on the presence of the vascular endothelium. However, inhibitors of the sGC pathway prevented the vasodilatory activity of Lzm-S. In addition, Aspergillus niger catalase, which breaks down H 2 O 2 , as well as hydroxyl radical scavengers, which included hydroquinone and mannitol, prevented the effect of Lzm-S. Electrochemical sensors corroborated that Lzm-S caused H 2 O 2 release from the carotid artery preparation. In conclusion, these results support the notion that when Lzm-S interacts with the arterial vasculature, this interaction results in the formation of H 2 O 2 , which, in turn, activates the sGC pathway to cause relaxation. Lzm-S may contribute to the vasodilation that occurs in septic shock. reactive oxygen species; catalase; compound I; hydroxyl radical; septic shock; hypotension Address for reprint requests and other correspondence: S. N. Mink, Health Sciences Centre, GF-221, 820 Sherbrook St., Winnipeg, Manitoba, Canada R3A 1R9 (e-mail: minksn{at}cc.umanitoba.ca )</description><subject>Aminoquinolines - pharmacology</subject><subject>Animals</subject><subject>Blood vessels</subject><subject>Carotid Artery, Internal - drug effects</subject><subject>Carotid Artery, Internal - enzymology</subject><subject>Carotid Artery, Internal - metabolism</subject><subject>Catalase - metabolism</subject><subject>Cells</subject><subject>Cyclic GMP - analogs &amp; derivatives</subject><subject>Cyclic GMP - metabolism</subject><subject>Cyclic GMP - pharmacology</subject><subject>Cyclic GMP-Dependent Protein Kinases - antagonists &amp; inhibitors</subject><subject>Cyclic GMP-Dependent Protein Kinases - metabolism</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Dogs</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzymes</subject><subject>Ethanol - pharmacology</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Guanylate Cyclase - antagonists &amp; inhibitors</subject><subject>Guanylate Cyclase - metabolism</subject><subject>Humans</subject><subject>Hydrogen Peroxide - metabolism</subject><subject>Hydroquinones - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Indomethacin - pharmacology</subject><subject>Mannitol - pharmacology</subject><subject>Mesenteric Artery, Superior - drug effects</subject><subject>Mesenteric Artery, Superior - enzymology</subject><subject>Mesenteric Artery, Superior - metabolism</subject><subject>Methylene Blue - pharmacology</subject><subject>Muramidase - antagonists &amp; inhibitors</subject><subject>Muramidase - metabolism</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>omega-N-Methylarginine - pharmacology</subject><subject>Oxadiazoles - pharmacology</subject><subject>Phenylephrine - pharmacology</subject><subject>Prostaglandins - metabolism</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Quinoxalines - pharmacology</subject><subject>Receptors, Cytoplasmic and Nuclear - antagonists &amp; inhibitors</subject><subject>Receptors, Cytoplasmic and Nuclear - metabolism</subject><subject>Sepsis - metabolism</subject><subject>Sepsis - physiopathology</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Soluble Guanylyl Cyclase</subject><subject>Studies</subject><subject>Thionucleotides - pharmacology</subject><subject>Time Factors</subject><subject>Vasoconstrictor Agents - pharmacology</subject><subject>Vasodilation - drug effects</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF2L1DAYhYMo7rj6CwQJXtvZfDYtXsniusKAN-t1SNO3bYZOU5PU3frrzeyMqzdC4L3IeQ6HB6G3lGwplezK7OcBTEhbQoliW0aIeoY2-YcVVPL6OdoQXvKipFxeoFcx7gkhUpX8JbqgFSu5omKD4m6N_td6gA_Y4AO0ziQfsO9whDm6iNNgEp6DbxcLEf800bduNMn5CTcrHtY2-B4mPEPwD64FHF0_mdFNPXYTNvmFBMGZMXfAbMIj-Rq96MwY4c35XqLvN5_vrm-L3bcvX68_7QorGEuFkgxMyQ1rSNW0wpaV7Yg1glrFGWtMI2zVSFlJKohQ1tK2JtAQK0qoFSWcX6L3p968_8cCMem9X0KeFzVjdalkRY8hfgrZ4GMM0Ok5uIMJq6ZEHz3rP571o2d99Jypd-fqpcnW_jJnsTnw8RQYXD_cuwB6Htbo_Oj7Vd8s43gHD-mpmtVCC31LFRN6brtMX_2fftrzD8V_Axkko48</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Mink, Steven N</creator><creator>Kasian, Krika</creator><creator>Santos Martinez, Luis E</creator><creator>Jacobs, Hans</creator><creator>Bose, Ratna</creator><creator>Cheng, Zhao-Qin</creator><creator>Light, R. Bruce</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20080401</creationdate><title>Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation</title><author>Mink, Steven N ; Kasian, Krika ; Santos Martinez, Luis E ; Jacobs, Hans ; Bose, Ratna ; Cheng, Zhao-Qin ; Light, R. Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-752ea63a2b08bd4c68cf0ca41c7322bab4c8b558514047cc1d90eb0c46e971033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aminoquinolines - pharmacology</topic><topic>Animals</topic><topic>Blood vessels</topic><topic>Carotid Artery, Internal - drug effects</topic><topic>Carotid Artery, Internal - enzymology</topic><topic>Carotid Artery, Internal - metabolism</topic><topic>Catalase - metabolism</topic><topic>Cells</topic><topic>Cyclic GMP - analogs &amp; derivatives</topic><topic>Cyclic GMP - metabolism</topic><topic>Cyclic GMP - pharmacology</topic><topic>Cyclic GMP-Dependent Protein Kinases - antagonists &amp; inhibitors</topic><topic>Cyclic GMP-Dependent Protein Kinases - metabolism</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Dogs</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzymes</topic><topic>Ethanol - pharmacology</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Guanylate Cyclase - antagonists &amp; inhibitors</topic><topic>Guanylate Cyclase - metabolism</topic><topic>Humans</topic><topic>Hydrogen Peroxide - metabolism</topic><topic>Hydroquinones - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Indomethacin - pharmacology</topic><topic>Mannitol - pharmacology</topic><topic>Mesenteric Artery, Superior - drug effects</topic><topic>Mesenteric Artery, Superior - enzymology</topic><topic>Mesenteric Artery, Superior - metabolism</topic><topic>Methylene Blue - pharmacology</topic><topic>Muramidase - antagonists &amp; inhibitors</topic><topic>Muramidase - metabolism</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>omega-N-Methylarginine - pharmacology</topic><topic>Oxadiazoles - pharmacology</topic><topic>Phenylephrine - pharmacology</topic><topic>Prostaglandins - metabolism</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Quinoxalines - pharmacology</topic><topic>Receptors, Cytoplasmic and Nuclear - antagonists &amp; inhibitors</topic><topic>Receptors, Cytoplasmic and Nuclear - metabolism</topic><topic>Sepsis - metabolism</topic><topic>Sepsis - physiopathology</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Soluble Guanylyl Cyclase</topic><topic>Studies</topic><topic>Thionucleotides - pharmacology</topic><topic>Time Factors</topic><topic>Vasoconstrictor Agents - pharmacology</topic><topic>Vasodilation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mink, Steven N</creatorcontrib><creatorcontrib>Kasian, Krika</creatorcontrib><creatorcontrib>Santos Martinez, Luis E</creatorcontrib><creatorcontrib>Jacobs, Hans</creatorcontrib><creatorcontrib>Bose, Ratna</creatorcontrib><creatorcontrib>Cheng, Zhao-Qin</creatorcontrib><creatorcontrib>Light, R. Bruce</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mink, Steven N</au><au>Kasian, Krika</au><au>Santos Martinez, Luis E</au><au>Jacobs, Hans</au><au>Bose, Ratna</au><au>Cheng, Zhao-Qin</au><au>Light, R. Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>294</volume><issue>4</issue><spage>H1724</spage><epage>H1735</epage><pages>H1724-H1735</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>Departments of 1 Medicine, 2 Pharmacology and Therapeutics, and 3 Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada; and 4 Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico Submitted 15 September 2007 ; accepted in final form 6 February 2008 In septic shock, systemic vasodilation and myocardial depression contribute to the systemic hypotension observed. Both components can be attributed to the effects of mediators that are released as part of the inflammatory response. We previously found that lysozyme (Lzm-S), released from leukocytes, contributed to the myocardial depression that develops in a canine model of septic shock. Lzm-S binds to the endocardial endothelium, resulting in the production of nitric oxide (NO), which, in turn, activates the myocardial soluble guanylate cyclase (sGC) pathway. In the present study, we determined whether Lzm-S might also play a role in the systemic vasodilation that occurs in septic shock. In a phenylephrine-contracted canine carotid artery ring preparation, we found that both canine and human Lzm-S, at concentrations similar to those found in sepsis, produced vasorelaxation. This decrease in force could not be prevented by inhibitors of NO synthase, prostaglandin synthesis, or potassium channel inhibitors and was not dependent on the presence of the vascular endothelium. However, inhibitors of the sGC pathway prevented the vasodilatory activity of Lzm-S. In addition, Aspergillus niger catalase, which breaks down H 2 O 2 , as well as hydroxyl radical scavengers, which included hydroquinone and mannitol, prevented the effect of Lzm-S. Electrochemical sensors corroborated that Lzm-S caused H 2 O 2 release from the carotid artery preparation. In conclusion, these results support the notion that when Lzm-S interacts with the arterial vasculature, this interaction results in the formation of H 2 O 2 , which, in turn, activates the sGC pathway to cause relaxation. Lzm-S may contribute to the vasodilation that occurs in septic shock. reactive oxygen species; catalase; compound I; hydroxyl radical; septic shock; hypotension Address for reprint requests and other correspondence: S. N. Mink, Health Sciences Centre, GF-221, 820 Sherbrook St., Winnipeg, Manitoba, Canada R3A 1R9 (e-mail: minksn{at}cc.umanitoba.ca )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18263714</pmid><doi>10.1152/ajpheart.01072.2007</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2008-04, Vol.294 (4), p.H1724-H1735
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_journals_229675813
source MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aminoquinolines - pharmacology
Animals
Blood vessels
Carotid Artery, Internal - drug effects
Carotid Artery, Internal - enzymology
Carotid Artery, Internal - metabolism
Catalase - metabolism
Cells
Cyclic GMP - analogs & derivatives
Cyclic GMP - metabolism
Cyclic GMP - pharmacology
Cyclic GMP-Dependent Protein Kinases - antagonists & inhibitors
Cyclic GMP-Dependent Protein Kinases - metabolism
Cyclooxygenase Inhibitors - pharmacology
Dogs
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
Enzymes
Ethanol - pharmacology
Free Radical Scavengers - pharmacology
Guanylate Cyclase - antagonists & inhibitors
Guanylate Cyclase - metabolism
Humans
Hydrogen Peroxide - metabolism
Hydroquinones - pharmacology
In Vitro Techniques
Indomethacin - pharmacology
Mannitol - pharmacology
Mesenteric Artery, Superior - drug effects
Mesenteric Artery, Superior - enzymology
Mesenteric Artery, Superior - metabolism
Methylene Blue - pharmacology
Muramidase - antagonists & inhibitors
Muramidase - metabolism
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase - metabolism
omega-N-Methylarginine - pharmacology
Oxadiazoles - pharmacology
Phenylephrine - pharmacology
Prostaglandins - metabolism
Protein Kinase Inhibitors - pharmacology
Quinoxalines - pharmacology
Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors
Receptors, Cytoplasmic and Nuclear - metabolism
Sepsis - metabolism
Sepsis - physiopathology
Signal transduction
Signal Transduction - drug effects
Soluble Guanylyl Cyclase
Studies
Thionucleotides - pharmacology
Time Factors
Vasoconstrictor Agents - pharmacology
Vasodilation - drug effects
title Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lysozyme,%20a%20mediator%20of%20sepsis%20that%20produces%20vasodilation%20by%20hydrogen%20peroxide%20signaling%20in%20an%20arterial%20preparation&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Mink,%20Steven%20N&rft.date=2008-04-01&rft.volume=294&rft.issue=4&rft.spage=H1724&rft.epage=H1735&rft.pages=H1724-H1735&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.01072.2007&rft_dat=%3Cproquest_pubme%3E1460409241%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229675813&rft_id=info:pmid/18263714&rfr_iscdi=true